7892 Federal Register / Vol. 86, No. 20 / Tuesday, February 2, 2021 / Notices 

ATTACHMENT 1—GENERAL TARGET SCHEDULE FOR PROCESSING AND RESOLVING REQUESTS FOR ACCESS TO SENSITIVE

UNCLASSIFIED NON-SAFEGUARDS INFORMATION AND SAFEGUARDS INFORMATION IN THIS PROCEEDING—Continued 

Day Event/Activity 

>A + 60 ............. Decision on contention admission. 

[FR Doc. 2021–01310 Filed 2–1–21; 8:45 am] 

BILLING CODE 7590–01–P 

NUCLEAR REGULATORY 

COMMISSION 

Advisory Committee on the Medical 

Uses of Isotopes: Call for Nominations 

AGENCY: U.S. Nuclear Regulatory 

Commission. 

ACTION: Call for nominations. 

SUMMARY: The U.S. Nuclear Regulatory 

Commission (NRC) is soliciting 

nominations for the Health Care 

Administrator position on the Advisory 

Committee of the Medical Uses of 

Isotopes (ACMUI). Health Care 

Administrator nominees should have 

professional experience with and/or 

extensive knowledge about health care 

administration. Involvement and 

leadership in professional societies or 

organizations is preferred. 

DATES: Nominations are due on or 

before April 5, 2021. 

ADDRESSES: Nomination Process: 

Submit an electronic copy of resume or 

curriculum vitae, along with a cover 

letter, to Ms. Kellee Jamerson, 

Kellee.Jamerson@nrc.gov. The cover 

letter should describe the nominee’s 

current involvement with health care 

administration and express the 

nominee’s interest in the position. 

Please ensure that the resume or 

curriculum vitae includes the following 

information, if applicable: Education; 

certification(s); professional association 

and committee membership activities; 

and number of years, timeframe, and 

type of setting for health care 

administration. 

FOR FURTHER INFORMATION CONTACT: Ms. 

Kellee Jamerson, U.S. Nuclear 

Regulatory Commission, Office of 

Nuclear Material Safety and Safeguards; 

(301) 415–7408; Kellee.Jamerson@

nrc.gov. 

SUPPLEMENTARY INFORMATION: The 

ACMUI Health Care Administrator 

representative provides advice to the 

NRC staff on a broad perspective of 

various interests, to include, patients’ 

interests, physicians’ interests, and 

hospitals’ interests, as they apply to 

radiation safely, the treatment of 

patients, and NRC’s medical-use policy. 

This individual is appointed based on 

his or her educational background, 

certification(s), professional experience, 

involvement and/or leadership in 

professional societies or organizations, 

and other information obtained in 

letters or during the selection process. 

The ACMUI advises the NRC on 

policy and technical issues that arise in 

the regulation of the medical use of 

byproduct material. Responsibilities 

include providing comments on changes 

to the NRC regulations and guidance; 

evaluating certain non-routine uses of 

byproduct material; providing technical 

assistance in licensing, inspection, and 

enforcement cases; and bringing key 

issues to the attention of the NRC staff, 

for appropriate action. 

ACMUI members are selected based 

on their educational background, 

certification(s), work experience, 

involvement and/or leadership in 

professional society activities, and other 

information obtained from 

recommendation letters or during the 

selection process. Nominees should 

have the demonstrated ability to 

establish effective work relationships 

with peers and implement successful 

approaches to problem solving and 

conflict resolution. ACMUI members 

currently serve a four-year term and 

may be considered for reappointment to 

a second term. The current ACMUI 

membership is comprised of the 

following professionals: (a) Nuclear 

medicine physician; (b) nuclear 

cardiologist; (c) nuclear medicine 

physicist; (d) therapy medical physicist; 

(e) radiation safety officer; (f) nuclear 

pharmacist; (g) two radiation 

oncologists; (h) patients’ rights 

advocate; (i) Food and Drug 

Administration representative; (j) 

Agreement State representative; (k) 

healthcare administrator; and (l) 

diagnostic radiologist. For additional 

information about membership on the 

ACMUI, visit the ACMUI Membership 

web page, https://www.nrc.gov/aboutnrc/regulatory/advisory/acmui/ 

membership.html. 

Nominees must be U.S. citizens and 

be able to devote up to 160 hours per 

year to ACMUI business. Members are 

expected to attend semi-annual 

meetings in Rockville, Maryland and to 

participate in teleconferences or virtual 

meetings, as needed. Members who are 

not Federal employees are compensated 

for their service. In addition, members 

are reimbursed for travel (including per 

diem in lieu of subsistence) and are 

reimbursed secretarial and 

correspondence expenses. Full-time 

Federal employees are reimbursed for 

travel expenses only. 

Security Background Check: The 

selected nominee will undergo a 

thorough security background check. 

Security paperwork may take the 

nominee several weeks to complete. 

Nominees will also be required to 

complete a financial disclosure 

statement to avoid conflicts of interest. 

Dated at Rockville, Maryland this 27th day 

of January, 2021. 

For the U.S. Nuclear Regulatory 

Commission. 

Russell E. Chazell, 

Federal Advisory Committee Management 

Officer. 

[FR Doc. 2021–02112 Filed 2–1–21; 8:45 am] 

BILLING CODE 7590–01–P 

SECURITIES AND EXCHANGE 

COMMISSION 

[Investment Company Act Release No. 

34182; File No. 812–15099] 

Hamilton Lane Private Assets Fund, et 

al. 

January 28, 2021. 

AGENCY: Securities and Exchange 

Commission (‘‘Commission’’). 

ACTION: Notice. 

Notice of application for an order 

under sections 17(d) and 57(i) of the 

Investment Company Act of 1940 (the 

‘‘Act’’) and rule 17d–1 under the Act to 

permit certain joint transactions 

otherwise prohibited by sections 17(d) 

and 57(a)(4) of the Act and rule 17d–1 

under the Act. Applicants request an 

order to permit a closed-end 

management investment company to coinvest in portfolio companies with 

affiliated investment funds. 

APPLICANTS: Hamilton Lane Private 

Assets Fund (the ‘‘Fund’’), Hamilton 

Lane Advisors, L.L.C. (‘‘Hamilton 

Lane’’), 2020 Tactical Market Fund LP, 

Edgewood Partners LP, Fifth Stockholm 

CI SPV L.P., Finance Street AIV Splitter 

L.P., Florida Growth Fund II LLC, Green 

Core Fund, L.P., Hamilton Lane CoVerDate Sep<11>2014 20:09 Feb 01, 2021 Jkt 253001 PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 E:\FR\FM\02FEN1.SGM 02FEN1

jbell on DSKJLSW7X2PROD with NOTICES